Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantation

Bone Marrow Transplantation

Volumn 34, Issue 5, 2004, Pages 455-458

  Hon, C ^a   Mak, W ^a   Kwok, A K H ^a,b   Au, Wing Y ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Myasthenia; Ptosis; Stem cell transplantation

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; MUSCLE ANTIBODY; PYRIDOSTIGMINE; STEROID;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOIMMUNITY; ANTIBODY DETECTION; APONEUROSIS; ARTICLE; AWARENESS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FACE MUSCLE; FEMALE; FISHER EXACT TEST; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNITY; MALE; MEDICAL SPECIALIST; MYASTHENIA GRAVIS; MYELOMA; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; PTOSIS; RARE DISEASE; SEX DIFFERENCE; SKELETAL MUSCLE; STUDENT T TEST; SURGICAL TECHNIQUE; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLEPHAROPTOSIS; BONE MARROW TRANSPLANTATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; NEUROMUSCULAR JUNCTION; SEVERITY OF ILLNESS INDEX;

EID: 4544296194     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704608     Document Type: Article

References (17)

1. Mencucci R, Rossi Ferrini C, Bosi A et al. Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997; 7: 13-18.
2. Valls-Canals J, Montero J, Pradas J. Stimulated single fiber EMG of the frontalis muscle in the diagnosis of ocular myasthenia. Muscle Nerve 2000; 23: 779-783.
3. Barton JJ, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol 2000; 20: 7-20.
4. Annoymous. Single fiber EMG reference values: a collaborative effort. Ad Hoc Committee of the AAEM Special Interest Group on Single Fiber EMG. Muscle Nerve 1992; 15: 151-161.
5. Smith CI, Aarli JA, Biberfeld P et al. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. N Engl J Med 1983; 309: 1565-1568.
6. Melms A, Faul C, Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992; 9: 78-79.
7. Shimoda K, Gondo H, Harada M et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-156.
8. Mackey JR, Desai S, Larratt L et al. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997; 19: 939-942.
9. Grau JM, Casademont J, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990; 5: 435-437.
10. Yu YL, Hawkins BR, Ip MS et al. Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992; 86: 113-119.
11. Chiu HC, Hsieh RP, Hsieh KH, Hung TP. Association of HLA-DRw9 with myasthenia gravis in Chinese. J Immunogenet 1987; 14: 203-207.
12. Smith CI, Norberg R, Moller G et al. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. Eur Neurol 1989; 29: 128-134.
13. Cikes N, Momoi MY, Williams CL et al. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988; 63: 474-481.
14. Sommer N, Melms A, Weller M, Dichgans J. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol 1993; 84: 309-333.
15. Bradley EA, Bartley GB, Chapman KL, Waller RR. Surgical correction of blepharoptosis in patients with myasthenia gravis. Trans Am Ophthalmol Soc 2000; 98: 173-180 discussion 180-181.
16. Battu VK, Meyer DR, Wobig JL. Improvement in subjective visual function and quality of life outcome measures after blepharoptosis surgery. Am J Ophthalmol 1996; 121: 677-686.
17. Castronuovo S, Krohel GB, Kristan RW. Blepharoptosis in myasthenia gravis. Ann Ophthalmol 1983; 15: 751-754.